NCT05872659View on ClinicalTrials.gov

Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 16, 2023

Primary Completion Date

November 15, 2025

Study Completion Date

November 15, 2025

Conditions
AIDS VirusDisorder of Immune Reconstitution
Interventions
OTHER

normal saline

iv at D0, D30, D60

BIOLOGICAL

Mesenchymal stem cells

iv at D0, D30, D60

Trial Locations (1)

Unknown

RECRUITING

Shandong Public Health Clinical Center, Jinan

All Listed Sponsors
collaborator

Shandong Public Health Clinical Center

OTHER_GOV

lead

Shandong Qilu Cell Therapy Engineering Technology Co., Ltd

INDUSTRY